Enterprise Value
9.389M
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
0.32%
Insider Ownership
4.66%
Institutional Own.
6.33%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
D-PLEX₁₀₀ Details Surgical site infection | Phase 3 Data readout | |
D-PLEX₁₀₀ Details Surgical site infection | Phase 3 Data readout | |
D-PLEX₁₀₀ Details Surgical site infection, Interstitial lung disease, Pulmonary hypertension | Phase 3 Update |